Please use this identifier to cite or link to this item: https://hdl.handle.net/11499/6011
Title: Effects of catechol-O-methyltransferase enzyme Val158Met polymorphism on cognitive functions in schizophrenic patients
Authors: Varma, Gülfizar S.
Karadag, Filiz
Emin Erdal, M.
Ay, Ö.I.
Levent, N.
Tekkanat, Ç.
Gökdogan, E.T.
Herken, Hasan
Keywords: Attention
Catechol-O-methyltransferase (COMT)
Executive function
Memory
Schizophrenia
Val158Met polymorphism
catechol methyltransferase
methionine
valine
allele
article
attention
brain function
Brief Psychiatric Rating Scale
clinical article
clinical feature
cognition
controlled study
DNA isolation
drug effect
enzyme activity
enzyme polymorphism
executive function
female
genetic variability
human
male
neuropsychological test
polymerase chain reaction
prefrontal cortex
psychologic test
restriction fragment length polymorphism
scale for assessment of negative symptom
scale for assessment of positive symptom
schizophrenia
Stroop test
verbal memory
verbal memory process test
Wisconsin Card Sorting Test
working memory
Abstract: Objective: Catechol-O-Methyltransferase (COMT) enzyme plays an important role in dopamine metabolism. Three different genotypes have been defined, one resulting from a valine (val)›methionine (met) amino acid change due to a guanine›adenine nucleotide change at codon 108/158 of the COMT gene, while the other two genotypes are formed by alleles containing val (heat-resistant, high activity) and met (heat-sensitive, low activity). This functional polymorphism in the COMT gene causes an alteration in the enzyme activity, where the enzyme activity is reduced 4 times in genotypes related to low enzyme activity. In schizophrenic patients, alterations in the amounts and efficiency of dopamine are known to be related to the clinical symptoms and cognitive functions. This study aimed to investigate the effects of COMT Val158Met functional polymorphisms on clinical symptoms, executive functions related to prefrontal functions, and attention and verbal memory in schizophrenic patients. Method: Schizophrenic patients in remission, who were followed up at the Psychosis Clinics of Pamukkale University Faculty of Medicine, Department of Psychiatry between the years of 2007- 2009, were included in the study. The Brief Psychiatric Rating Scale (BPRS), the Scale for Assessment of Positive Symptoms (SAPS), and theScale for Assessment of Negative Symptoms (SANS), were used to evaluate the patients. Neuropsychological evaluation included the Wisconsin Card Sorting Test (WCST) for executive functions, the Verbal Memory Processes Test (VMPT) for verbal memory and the Stroop Test (ST) for attention tasks. COMT enzyme Val158Met polymorphisms were defined from the isolated DNA of the patients by Polymerase Chain Reaction (PCR) and Restriction Fragment Length Polymorphism (RFLP) analysis, as defined in literature. Results: A total of 42 patients (16 female, 26 male) were included in the study. The patients were grouped into high-level enzyme activity (Val/Val) and low-level enzyme activity (Val/Met and Met/Met) groups, according to their COMT Val158Met functional polymorphisms, and statistical analysis was carried out accordingly. Patients with Val/Val polymorphism had lower SANS scores, while the number of conceptual level responses, the percentage of conceptual level responses, and the failure to maintenance set scores at WCST were lower compared to those with the met allele. No difference was determined between the two groups in the scores on the SAPS and BPRS, and on the performance of the Stroop Test and the VPMT. Conclusion: We measured lower levels of negative symptoms in patients with high enzyme activity compared to those with low enzyme activity. There was no difference in executive functions assessed with the WCST in scores related to perseveration, while the patients with high enzyme activity presented a better performance in the fields related to working memory. Although the small subject number of the study represents a serious limitation, these results suggest that COMT Val158Met polymorphism has a limited effect on clinical symptoms and executive functions, but no effect on attention level and memory in schizophrenia.
URI: https://hdl.handle.net/11499/6011
ISSN: 1017-7833
Appears in Collections:Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
Tıp Fakültesi Koleksiyonu
TR Dizin İndeksli Yayınlar Koleksiyonu / TR Dizin Indexed Publications Collection
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection

Files in This Item:
File SizeFormat 
dc068e51-4279-42e2-bc40-fb0f23547357.pdf385.43 kBAdobe PDFView/Open
Show full item record



CORE Recommender

SCOPUSTM   
Citations

5
checked on Dec 14, 2024

WEB OF SCIENCETM
Citations

4
checked on Dec 20, 2024

Page view(s)

68
checked on Aug 24, 2024

Download(s)

44
checked on Aug 24, 2024

Google ScholarTM

Check





Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.